Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 16972738 | CLEAVABLE CO-OPERATIVE PRIMERS AND METHOD OF AMPLIFYING NUCLEIC ACID SEQUENCES USING SAME | December 2020 | October 2023 | Abandon | 34 | 0 | 1 | No | No |
| 16975542 | METHOD FOR PRIMER EXTENSION REACTION WITH IMPROVED SPECIFICITY | November 2020 | October 2023 | Abandon | 37 | 0 | 1 | No | No |
| 17099093 | Method for Identifying Gene Fusions by Circle cDNA Amplification | November 2020 | June 2023 | Allow | 31 | 2 | 0 | Yes | No |
| 17080813 | METHODS OF ANALYSIS OF METHYLATION | October 2020 | November 2023 | Abandon | 36 | 0 | 1 | No | No |
| 17038412 | SMALL RNA DETECTION METHOD BASED ON SMALL RNA PRIMED XENOSENSOR MODULE AMPLIFICATION | September 2020 | November 2022 | Allow | 25 | 1 | 1 | Yes | No |
| 17032414 | GENE RELEVANT TO PAPILLARY THYROID TUMORS | September 2020 | July 2023 | Abandon | 33 | 2 | 1 | No | No |
| 16927353 | METHODS FOR DETECTING NUCLEIC ACID SEQUENCE VARIANTS | July 2020 | October 2024 | Abandon | 51 | 2 | 1 | No | No |
| 16959983 | ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY MINOR GROOVE BINDING MOIETIES | July 2020 | April 2024 | Abandon | 46 | 3 | 1 | No | No |
| 16919238 | METHODS OF NUCLEIC ACID SAMPLE PREPARATION | July 2020 | July 2023 | Allow | 36 | 1 | 1 | No | No |
| 16958797 | PAPER-BASED COLORIMETRIC SENSOR KIT FOR QUICKLY AND SIMPLY DIAGNOSING MERCURY IN SITU WITH NAKED EYE AND METHOD FOR QUICKLY AND SIMPLY DETECTING MERCURY IN SITU WITH NAKED EYE USING THE SAME | June 2020 | July 2022 | Allow | 25 | 2 | 0 | No | No |
| 16906165 | METHODS AND COMPOSITIONS FOR SIZE-CONTROLLED HOMOPOLYMER TAILING OF SUBSTRATE POLYNUCLEOTIDES BY A NUCLEIC ACID POLYMERASE | June 2020 | May 2021 | Allow | 10 | 1 | 0 | Yes | No |
| 16956552 | IMPROVEMENTS IN OR RELATING TO AMPLIFICATION OF NUCLEIC ACIDS | June 2020 | June 2022 | Allow | 24 | 2 | 0 | No | No |
| 16897588 | METHODS FOR DETERMINING A NUCLEOTIDE SEQUENCE CONTIGUOUS TO A KNOWN TARGET NUCLEOTIDE SEQUENCE | June 2020 | December 2022 | Allow | 30 | 2 | 0 | Yes | No |
| 16769229 | Compositions and Methods for Detecting Toxigenic Clostridium Difficile | June 2020 | June 2024 | Allow | 48 | 2 | 3 | Yes | No |
| 16768356 | METHOD FOR AMPLIFYING TARGET NUCLEIC ACID AND COMPOSITION FOR AMPLIFYING TARGET NUCLEIC ACID | May 2020 | December 2022 | Allow | 31 | 2 | 1 | No | No |
| 16849344 | Single Cell Genomic Sequencing Using Hydrogel Based Droplets | April 2020 | May 2021 | Allow | 13 | 3 | 1 | Yes | No |
| 16804695 | METHODS OF NUCLEIC ACID SAMPLE PREPARATION FOR ANALYSIS OF DNA | February 2020 | February 2022 | Allow | 24 | 1 | 1 | No | No |
| 16803731 | A NANOSTRUCTURE, A BIOSENSOR INCLUDING THE NANOSTRUCTURE, AND A SCREENING METHOD | February 2020 | January 2023 | Allow | 35 | 1 | 1 | No | No |
| 16638346 | DIGITAL AMPLIFICATION WITH PRIMERS OF LIMITED NUCLEOTIDE COMPOSITION | February 2020 | April 2023 | Allow | 38 | 2 | 1 | Yes | No |
| 16751000 | METHOD FOR INCREASING POLYMERASE PROCESSIVITY | January 2020 | April 2022 | Abandon | 27 | 0 | 1 | No | No |
| 16735372 | POLYNUCLEOTIDE AMPLIFICATION USING CRISPR-CAS SYSTEMS | January 2020 | April 2024 | Allow | 51 | 2 | 1 | No | No |
| 16619999 | METHOD FOR DIAGNOSING ATOPIC DERMATITIS THROUGH MICROBIAL METAGENOMIC ANALYSIS | December 2019 | August 2023 | Abandon | 44 | 2 | 2 | Yes | No |
| 16700493 | CAPTURE OF NUCLEIC ACIDS USING A NUCLEIC ACID-GUIDED NUCLEASE-BASED SYSTEM | December 2019 | February 2023 | Abandon | 38 | 2 | 1 | No | Yes |
| 16667092 | BORDETELLA DETECTION ASSAY | October 2019 | July 2022 | Allow | 32 | 1 | 0 | No | No |
| 16605367 | SWITCH-LIKE ISOTHERMAL DNA AMPLIFICATION DEMONSTRATING A NON-LINEAR AMPLIFICATION RATE | October 2019 | May 2024 | Abandon | 55 | 2 | 1 | No | No |
| 16601204 | DETECTION OF SEQUENCES UNIQUELY ASSOCIATED WITH A DNA TARGET REGION | October 2019 | November 2020 | Allow | 13 | 2 | 1 | No | No |
| 16581129 | Method for Blocking miRNA | September 2019 | June 2023 | Allow | 44 | 2 | 1 | Yes | No |
| 16576583 | METHODS AND COMPOSITIONS FOR DNA PROFILING | September 2019 | July 2022 | Allow | 34 | 2 | 1 | No | No |
| 16543963 | DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN BIOLOGICAL SAMPLES | August 2019 | January 2023 | Allow | 41 | 3 | 0 | Yes | No |
| 16484192 | COMPOSITION FOR POLYMERASE REACTION | August 2019 | April 2023 | Allow | 44 | 2 | 1 | Yes | No |
| 16533444 | DILUTION TAGGING FOR QUANTIFICATION OF BIOLOGICAL TARGETS | August 2019 | April 2024 | Allow | 56 | 4 | 1 | Yes | No |
| 16528222 | METHODS OF ANALYSIS OF METHYLATION | July 2019 | September 2020 | Allow | 13 | 2 | 1 | No | No |
| 16511304 | METHODS OF REDUCING DENSITY-DEPENDENT GC BIAS IN AMPLIFICATION | July 2019 | July 2020 | Allow | 13 | 1 | 1 | Yes | No |
| 16455828 | METHOD AND SYSTEM FOR SUBSTANCE DETECTION WITH A MAGNETIC SENSOR | June 2019 | July 2023 | Abandon | 48 | 4 | 1 | Yes | No |
| 16431039 | GENETIC ARRAY FOR SIMULTANEOUS DETECTION OF MULTIPLE SALMONELLA SEROVARS | June 2019 | July 2022 | Allow | 38 | 2 | 1 | Yes | No |
| 16412353 | METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI | May 2019 | November 2019 | Abandon | 6 | 0 | 1 | No | No |
| 16411770 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | May 2019 | December 2021 | Allow | 31 | 3 | 2 | Yes | No |
| 16412043 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | May 2019 | December 2021 | Allow | 31 | 3 | 2 | Yes | No |
| 16411585 | SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND DETERMINING CHROMOSOME COPY NUMBER | May 2019 | July 2020 | Abandon | 14 | 2 | 0 | Yes | No |
| 16411677 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | May 2019 | November 2020 | Abandon | 18 | 2 | 1 | No | No |
| 16401535 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | May 2019 | October 2019 | Abandon | 6 | 0 | 1 | No | No |
| 16399911 | SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND DETERMINING CHROMOSOME COPY NUMBER | April 2019 | October 2020 | Abandon | 18 | 2 | 0 | Yes | Yes |
| 16399794 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | April 2019 | December 2020 | Abandon | 19 | 2 | 1 | No | No |
| 16395154 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | April 2019 | December 2020 | Abandon | 20 | 2 | 1 | No | No |
| 16383279 | INCREASED SIGNAL TO NOISE IN NUCLEIC ACID SEQUENCING | April 2019 | January 2022 | Allow | 33 | 1 | 1 | Yes | No |
| 16360843 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | March 2019 | July 2019 | Abandon | 4 | 0 | 0 | No | No |
| 16289049 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | February 2019 | March 2021 | Abandon | 25 | 2 | 1 | No | No |
| 16289528 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | February 2019 | August 2020 | Abandon | 18 | 1 | 1 | No | No |
| 16325247 | DOUBLE-STRANDED CIRCLE PROBES | February 2019 | December 2022 | Allow | 46 | 2 | 0 | No | No |
| 16314356 | RNA REVERSE TRANSCRIPTION AMPLIFICATION METHOD | December 2018 | August 2021 | Abandon | 31 | 1 | 0 | No | No |
| 16313750 | IMPROVEMENTS IN OR RELATING TO NUCLEIC ACID AMPLIFICATION PROCESSES | December 2018 | December 2021 | Allow | 36 | 2 | 1 | Yes | No |
| 16223053 | Polymerase Assay with a FRET Substrate | December 2018 | January 2021 | Allow | 25 | 3 | 1 | No | No |
| 16210284 | TRANSPOSON END COMPOSITIONS AND METHODS FOR MODIFYING NUCLEIC ACIDS | December 2018 | May 2021 | Allow | 29 | 1 | 1 | Yes | No |
| 16209785 | METHOD AND KIT FOR ESTIMATING THE AMOUNT OF A METHYLATED LOCUS IN A SAMPLE | December 2018 | October 2020 | Allow | 23 | 0 | 0 | Yes | No |
| 16196684 | SYSTEMS AND METHODS FOR PREPARING NUCLEIC ACID MOLECULES FOR CHROMATIN ANALYSIS | November 2018 | April 2022 | Abandon | 41 | 4 | 2 | Yes | No |
| 16178262 | Analyte Enrichment Methods and Compositions | November 2018 | November 2019 | Allow | 13 | 1 | 0 | No | No |
| 16155771 | METHODS FOR GENOTYPING | October 2018 | December 2021 | Allow | 38 | 3 | 0 | Yes | No |
| 16108612 | KITS COMPRISING NUCLEIC ACID TEMPLATES AND PRIMERS FOR USE IN PRE-AMPLIFICATION ASSAYS | August 2018 | May 2021 | Allow | 33 | 1 | 1 | Yes | No |
| 16078261 | NUCLEIC ACID SEQUENCING METHOD AND SYSTEM EMPLOYING ENHANCED DETECTION OF NUCLEOTIDE-SPECIFIC TERNARY COMPLEX FORMATION | August 2018 | January 2021 | Allow | 29 | 1 | 1 | Yes | No |
| 16105057 | METHOD OF DESIGNING PRIMERS, METHOD OF DETECTING SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs), METHOD OF DISTINGUISHING SNPs, AND RELATED PRIMERS, DETECTABLE OLIGONUCLEOTIDES, AND KITS | August 2018 | November 2020 | Abandon | 27 | 0 | 1 | No | No |
| 16036511 | METHODS AND COMPOSITIONS FOR ISOLATING ASYMMETRIC NUCLEIC ACID COMPLEXES | July 2018 | October 2020 | Allow | 27 | 1 | 0 | Yes | No |
| 16067191 | INDEXING BASED DEEP DNA SEQUENCING TO IDENTIFY RARE SEQUENCES | June 2018 | June 2020 | Allow | 24 | 1 | 1 | Yes | No |
| 16021670 | Scavenger Compounds for Improved Sequencing-by-Synthesis | June 2018 | November 2020 | Abandon | 29 | 0 | 1 | No | No |
| 16017340 | COMPOSITIONS AND METHODS FOR TARGETED NUCLEIC ACID SEQUENCE ENRICHMENT AND HIGH EFFICIENCY LIBRARY GENERATION | June 2018 | August 2020 | Allow | 26 | 1 | 0 | No | No |
| 16061065 | ISOTHERMAL AMPLIFICATION FOR THE DETECTION OF INFLUENZA VIRUSES IN A SAMPLE | June 2018 | February 2022 | Abandon | 44 | 3 | 1 | Yes | No |
| 16001279 | CRUDE BIOLOGICAL DERIVATIVES COMPETENT FOR NUCLEIC ACID DETECTION | June 2018 | January 2019 | Allow | 7 | 1 | 0 | Yes | No |
| 15990400 | NMR SYSTEMS AND METHODS FOR THE RAPID DETECTION OF ANALYTES | May 2018 | July 2020 | Abandon | 26 | 2 | 1 | No | No |
| 15984612 | METHODS FOR DETERMINING A NUCLEOTIDE SEQUENCE CONTIGUOUS TO A KNOWN TARGET NUCLEOTIDE SEQUENCE | May 2018 | April 2020 | Allow | 23 | 1 | 0 | Yes | No |
| 15976701 | METHOD FOR NUCLEIC ACID SEQUENCING | May 2018 | October 2019 | Allow | 17 | 0 | 0 | Yes | No |
| 15772865 | METHOD FOR EXTRACTING AND CHARACTERIZING MOLECULAR CLONES | May 2018 | December 2023 | Abandon | 60 | 6 | 1 | No | No |
| 15967397 | METHOD FOR MEASURING TUMOR BURDEN IN PATIENT DERIVED XENOGRAFT (PDX) MICE | April 2018 | March 2021 | Allow | 34 | 2 | 1 | No | No |
| 15966353 | LIGATION-BASED RNA AMPLIFICATION | April 2018 | April 2020 | Allow | 23 | 1 | 1 | Yes | No |
| 15953304 | METHODS AND SYSTEMS FOR NUCLEIC ACID AMPLIFICATION | April 2018 | October 2020 | Abandon | 30 | 0 | 1 | No | No |
| 15937327 | DEVICES, SYSTEMS AND METHODS FOR NUCLEIC ACID SEQUENCING | March 2018 | February 2021 | Abandon | 35 | 1 | 1 | No | No |
| 15926341 | UNIVERSAL HAIRPIN PRIMERS | March 2018 | November 2020 | Allow | 32 | 2 | 1 | Yes | No |
| 15756441 | Method for Exploring Useful Genetic Resources Through Bulk Metagenome Analysis and Use Thereof | February 2018 | January 2022 | Allow | 47 | 3 | 1 | Yes | No |
| 15905952 | METHODS AND KITS FOR DEPLETING UNDESIRED NUCLEIC ACIDS | February 2018 | July 2022 | Allow | 53 | 5 | 1 | Yes | No |
| 15907163 | LARGE-SCALE SYNTHESIS OF MESSENGER RNA | February 2018 | September 2022 | Allow | 55 | 3 | 1 | Yes | No |
| 15754194 | DUMBBELL- PCR: A METHOD TO QUANTIFY SPECIFIC SMALL RNA VARIANTS WITH A SINGLE NUCLEOTIDE RESOLUTION AT TERMINAL SEQUENCES | February 2018 | August 2022 | Allow | 54 | 3 | 1 | Yes | No |
| 15900942 | NUCLEIC ACID AMPLIFICATION METHOD PRODUCING URACIL-CONTAINING AMPLIFICATION PRODUCTS | February 2018 | October 2020 | Allow | 32 | 1 | 1 | Yes | No |
| 15898460 | METHODS AND COMPOSITIONS FOR SIZE-CONTROLLED HOMOPOLYMER TAILING OF SUBSTRATE POLYNUCLEOTIDES BY A NUCLEIC ACID POLYMERASE | February 2018 | March 2020 | Allow | 25 | 1 | 0 | Yes | No |
| 15569981 | Use of molecular marker DKK-3 associated with muscle atrophy | February 2018 | March 2022 | Allow | 53 | 4 | 1 | Yes | No |
| 15883431 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | January 2018 | August 2020 | Abandon | 30 | 0 | 1 | No | No |
| 15881384 | SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND DETERMINING CHROMOSOME COPY NUMBER | January 2018 | December 2018 | Allow | 11 | 2 | 0 | Yes | No |
| 15881488 | SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND DETERMINING CHROMOSOME COPY NUMBER | January 2018 | April 2019 | Allow | 15 | 2 | 1 | Yes | No |
| 15877214 | DIRECT QUANTITATIVE PCR DEVICE AND METHOD OF USE THEREOF | January 2018 | May 2020 | Abandon | 28 | 0 | 1 | No | No |
| 15875816 | SELECTIVE AMPLIFICATION USING BLOCKING OLIGONUCLEOTIDES | January 2018 | February 2022 | Allow | 49 | 4 | 1 | Yes | No |
| 15864500 | COMPOSITIONS AND METHODS FOR DETECTING MECC-CONTAINING METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS | January 2018 | September 2018 | Allow | 8 | 1 | 0 | Yes | No |
| 15739672 | PRIMER SET FOR 1,4-DIOXANE-DEGRADING BACTERIA, AND METHOD FOR DETECTING AND QUANTIFYING 1,4-DIOXANE-DEGRADING BACTERIA | December 2017 | April 2019 | Abandon | 16 | 1 | 0 | No | No |
| 15831998 | Lipid-polymer Hybrid Nanoparticle Biochip and Application Thereof | December 2017 | March 2021 | Abandon | 39 | 2 | 1 | No | No |
| 15825553 | GENE SYNTHESIS PROCESS, GENE CHIP AND KIT | November 2017 | November 2020 | Abandon | 36 | 2 | 0 | No | No |
| 15816571 | MOLECULAR IDENTIFICATION METHOD FOR SINGLE DINOFLAGELLATE CYST | November 2017 | July 2019 | Allow | 20 | 2 | 0 | Yes | No |
| 15816738 | HIGHLY SENSITIVE METHODS FOR DETECTING BTK RESISTANCE MUTATIONS IN RNA AND DNA | November 2017 | March 2021 | Abandon | 40 | 2 | 1 | No | No |
| 15810383 | GENE RELEVANT TO PAPILLARY THYROID TUMORS | November 2017 | January 2021 | Abandon | 38 | 4 | 1 | Yes | No |
| 15809162 | METHOD OF DIAGNOSING NEOPLASMS | November 2017 | June 2019 | Abandon | 19 | 2 | 0 | No | No |
| 15807474 | PREDICTING BREAST CANCER TREATMENT OUTCOME | November 2017 | September 2018 | Abandon | 10 | 1 | 0 | No | No |
| 15805871 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | November 2017 | March 2020 | Abandon | 29 | 4 | 1 | No | No |
| 15806047 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | November 2017 | October 2019 | Abandon | 24 | 3 | 1 | No | No |
| 15804693 | Method for Studying V(D)J Combinatory Diversity | November 2017 | July 2023 | Allow | 60 | 2 | 1 | Yes | No |
| 15805095 | IDENTIFICATION OF GENE ASSOCIATED WITH READING DISABILITY AND USES THEREFOR | November 2017 | August 2019 | Abandon | 21 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BERTAGNA, ANGELA MARIE.
With a 16.7% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 7.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner BERTAGNA, ANGELA MARIE works in Art Unit 1637 and has examined 687 patent applications in our dataset. With an allowance rate of 32.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 39 months.
Examiner BERTAGNA, ANGELA MARIE's allowance rate of 32.8% places them in the 5% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by BERTAGNA, ANGELA MARIE receive 2.49 office actions before reaching final disposition. This places the examiner in the 68% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by BERTAGNA, ANGELA MARIE is 39 months. This places the examiner in the 25% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +54.6% benefit to allowance rate for applications examined by BERTAGNA, ANGELA MARIE. This interview benefit is in the 94% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 13.8% of applications are subsequently allowed. This success rate is in the 11% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 28.4% of cases where such amendments are filed. This entry rate is in the 41% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 25.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 29% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 60.0% of appeals filed. This is in the 35% percentile among all examiners. Of these withdrawals, 77.8% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 61.8% are granted (fully or in part). This grant rate is in the 64% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 1.5% of allowed cases (in the 71% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 7.1% of allowed cases (in the 87% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.